DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone.
Documents First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2...

Slide 1First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their…

Updates in the Treatment of Breast cancer Mohammad Jahanzeb, MD, FACP Professor of Clinical Medicine, Hematology-Oncology Director, UM Sylvester Deerfield.
Documents Updates in the Treatment of Breast cancer Mohammad Jahanzeb, MD, FACP Professor of Clinical...

Slide 1 Updates in the Treatment of Breast cancer Mohammad Jahanzeb, MD, FACP Professor of Clinical Medicine, Hematology-Oncology Director, UM Sylvester Deerfield Campus…

Breast Plenary Abstracts How Do These Studies Impact Clinical Practice Today and in the Years Ahead? Presented By Eric Winer at 2014 ASCO Annual Meeting.
Documents Breast Plenary Abstracts How Do These Studies Impact Clinical Practice Today and in the Years Ahead?...

Slide 1 Breast Plenary Abstracts How Do These Studies Impact Clinical Practice Today and in the Years Ahead? Presented By Eric Winer at 2014 ASCO Annual Meeting Slide 2 First…

Presented By Martine Piccart-Gebhart at 2014 ASCO Annual Meeting
Documents Presented By Martine Piccart-Gebhart at 2014 ASCO Annual Meeting

Slide 1 First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their…

Presented By Eric Winer at 2014 ASCO Annual Meeting
Documents Presented By Eric Winer at 2014 ASCO Annual Meeting

Slide 1 Breast Plenary AbstractsHow Do These Studies Impact Clinical Practice Today and in the Years Ahead? Presented By Eric Winer at 2014 ASCO Annual Meeting First results…

Popular Categories
Relevant Tags